Provided by Tiger Trade Technology Pte. Ltd.

SPYRE THERAPEUTICS INC

92.68
+1.511.66%
Post-market: 92.690.0100+0.01%17:53 EDT
Volume:1.44M
Turnover:133.60M
Market Cap:8.17B
PE:-46.11
High:95.19
Open:92.86
Low:91.14
Close:91.17
52wk High:110.18
52wk Low:14.51
Shares:88.17M
Float Shares:80.98M
Volume Ratio:1.44
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-1.9755
ROE:-22.98%
ROA:-19.81%
PB:8.56
PE(LYR):-46.92

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 09

Spyre Therapeutics (SYRE) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Sep 09

Analysts’ Top Healthcare Picks: Spyre Therapeutics (SYRE), BioCryst (BCRX)

TIPRANKS
·
Sep 09

Spyre Therapeutics' SPY003 Meets Phase 2 Primary Endpoint in Ulcerative Colitis

MT Newswires Live
·
Sep 08

Spyre Therapeutics announces 12-week induction data from Part A of SKYLINE trial

TIPRANKS
·
Sep 08

Spyre Reports Positive Phase 2 Skyline Part a Induction Data for UC Drug Spy003, Hits Primary Endpoint

Reuters
·
Sep 08

Spyre Therapeutics - Spy003 Meets Primary Endpoint with 10.0-Point Rhi Reduction at Week 12

THOMSON REUTERS
·
Sep 08

Spyre Therapeutics - Spy003 Well Tolerated with Safety Profile Consistent with Il-23 Class

THOMSON REUTERS
·
Sep 08

Spyre Therapeutics - Spy003 Achieves 20% Clinical Remission and 30% Endoscopic Improvement at Week 12

THOMSON REUTERS
·
Sep 08

Spyre Therapeutics - Skyline Part B Enrolling; Topline Induction Data Expected in 2027

THOMSON REUTERS
·
Sep 08

Spyre Therapeutics Grants Inducement Awards of 2,106 Stock Options, 745 RSUs to New Employee

Reuters
·
Sep 05

Spyre Therapeutics Announces Grants of Inducement Awards

GlobeNewswire
·
Sep 05

Spyre Therapeutics CEO Turtle Cameron Disposes of 15,000 Common Shares Worth $1.31 Million

Reuters
·
Sep 04

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

TIPRANKS
·
Aug 29

U.S. Research Roundup-CrowdStrike, Nvidia, Macerich

Reuters
·
Aug 27

Top Midday Decliners

MT Newswires Live
·
Aug 27

Spyre Therapeutics falls -13.2%

TIPRANKS
·
Aug 27

Spyre Therapeutics Down over 12%, on Pace for Largest Percent Decrease Since June 2024

Dow Jones
·
Aug 26

U.S. Stocks on the MOVE-Semtech, Donaldson, Meta

Reuters
·
Aug 26

Spyre Therapeutics (SYRE) Gets a Buy from LifeSci Capital

TIPRANKS
·
Aug 26